Goldmann G, Berens C, Marquardt N, Reich R, Oldenburg J, Wenghoefer M
Institute of Experimental Hematology and Transfusion Medicine (IHT), University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.
Oral Maxillofac Surg. 2015 Jun;19(2):195-200. doi: 10.1007/s10006-014-0476-z. Epub 2014 Dec 10.
In order to evaluate complication rates of dentoalveolar surgery in patients with congenital bleeding disorders, a retrospective case-control study was performed.
A collective of patients with congenital bleeding disorders (n = 69), who received common oral surgery procedures in combination with intense perioperative monitoring and coagulation factor substitution at the University Hospital of Bonn between 1992 and 2011, was matched with patients without bleeding disorders by age, sex, and type of surgery. In addition to the rates of perioperative bleeding and other complications, the duration of surgery and the use of local hemostatic agents were compared between both cohorts.
There were no significant differences between the two groups regarding the rate of postoperative bleeding (2.9 vs. 1.4%, patients with congenital bleeding disorders vs controls) and the rate of other complications (7.2 vs. 21.7%). Furthermore, no significant difference in operation time (54 min in patients with congenital bleeding disorders vs 45 min in controls) was observed. However, there was a significant difference (p < 0.001) regarding the use of local hemostatic measures, which were applied in all patients with hereditary bleeding disorders but in only one of the controls. All patients with bleeding disorders were inpatients, while all controls were treated in an outpatient setting.
If adequate measures are taken, the complication rate following oral surgery in patients with hereditary bleeding disorders can be reduced to that of patients without bleeding disorders. However, these results are reached at significant costs due to coagulation factor replacement and inpatient treatment.
为了评估先天性出血性疾病患者牙槽外科手术的并发症发生率,进行了一项回顾性病例对照研究。
选取1992年至2011年期间在波恩大学医院接受普通口腔外科手术并接受强化围手术期监测及凝血因子替代治疗的先天性出血性疾病患者群体(n = 69),按照年龄、性别和手术类型与无出血性疾病的患者进行匹配。除了比较围手术期出血率和其他并发症发生率外,还比较了两组患者的手术时间以及局部止血剂的使用情况。
两组在术后出血率(先天性出血性疾病患者为2.9%,对照组为1.4%)和其他并发症发生率(7.2%对21.7%)方面无显著差异。此外,观察到手术时间也无显著差异(先天性出血性疾病患者为54分钟,对照组为45分钟)。然而,在局部止血措施的使用方面存在显著差异(p < 0.001),所有遗传性出血性疾病患者均使用了局部止血措施,而对照组仅1例使用。所有出血性疾病患者均为住院患者,而所有对照组患者均在门诊接受治疗。
如果采取适当措施,遗传性出血性疾病患者口腔手术后的并发症发生率可降至无出血性疾病患者的水平。然而,由于凝血因子替代和住院治疗,这些结果的达成成本高昂。